Celecoxib/Tramadol Hydrochloride

塞来昔布/盐酸曲马多

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCelecoxib/Tramadol Hydrochloride
Drug Alias NameTramadol Hydrochloride/Celecoxib盐酸曲马多/塞来昔布Celecoxib/TramadolTramadol/CelecoxibE-58425 +[6] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-2 inhibitorsMu opioid receptor agonists
TargetsCyclooxygenase-2Mu opioid receptor
Therapy Area/IndicationsAcute PainPain, Postoperative
Global Approved IndicationsAcute Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/10/15
Country/TerritoryUnited StatesMainland China
CombinationsYes Tramadol HydrochlorideCelecoxib
Global Highest StatusApproved
Highest Status in ChinaIND
Originator CompaniesEsteve Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesMundipharma Research LtdLaboratorios Del Dr Esteve SaEsteve Pharmaceuticals Sa +[4] 
Inactive CompaniesKowa Pharmaceuticals America IncEsteve Pharmaceuticals LLC
Active IndicationsAcute Pain
Inactive IndicationsPain, Postoperative

Other Information

ATC CodeN/A
Related LinksN/A